Loading...
VEA Impex (I) Private Limited — Darunavir Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #9 for Darunavir · $59.4K export value · DGFT Verified
VEA Impex (I) Private Limited is the #9 Indian exporter of Darunavir with $59.4K in export value and 4 verified shipments. VEA Impex (I) Private Limited holds a 0.1% market share in Darunavir exports across 2 countries. The company exports 14 pharmaceutical products worth $229.9K across 3 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $2.6M | 53 | 16.1% |
| UNITED STATES | $2.5M | 49 | 14.9% |
| NETHERLANDS | $2.1M | 71 | 12.6% |
| FRANCE | $1.6M | 31 | 9.4% |
| SOUTH AFRICA | $1.3M | 25 | 7.6% |
| PERU | $1.2M | 24 | 7.3% |
| MEXICO | $800.0K | 16 | 4.9% |
| ETHIOPIA | $800.0K | 16 | 4.9% |
| KENYA | $750.0K | 15 | 4.6% |
| ALGERIA | $650.0K | 13 | 4.0% |
India exports Darunavir to 114 countries. The top destination is UNITED KINGDOM (16.1%), followed by UNITED STATES and NETHERLANDS.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MYLAN IRELAND C/O ALLOGA RDC, | NETHERLANDS | $999.6K | 33 |
| CIPLA USA INC UPS SUPPLY CHAIN SOLU | UNITED STATES | $600.0K | 12 |
| CSP VIATRIS SANTE AT CSP-LAB | FRANCE | $600.0K | 12 |
| PHARMARIS CHILE SPA, | CHILE | $400.0K | 8 |
| NATIONAL MEDICAL STORES | UGANDA | $300.0K | 6 |
India exported $33.1M worth of Darunavir through 711 shipments from 28 suppliers to 114 countries, serving 258 buyers globally. VEA Impex (I) Private Limited contributes $59.4K to this total, accounting for 0.1% of India's Darunavir exports.
VEA Impex (I) Private Limited's average Darunavir shipment value is $14.9K per consignment, based on 4 shipments totaling $59.4K.
VEA Impex (I) Private Limited ranks #9 among 28 Indian Darunavir exporters with a 0.1% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($13.4M), HETERO LABS LIMITED ($11.3M), MSN LABORATORIES PRIVATE LIMITED ($3.2M). VEA Impex (I) Private Limited processed 4 shipments to 2 destination countries.
What VEA Impex (I) Private Limited must comply with to export Darunavir to its top destination countries
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | LUPIN LIMITED | $250.0K | 5 | 1 | $50.0K |
| 8 | EMCURE PHARMACEUTICALS LIMITED | $176.5K | 18 | 2 | $9.8K |
| 9 | VEA IMPEX (I) PRIVATE LIMITED ★ | $59.4K | 4 | 2 | $14.9K |
| 10 | SAIMIRRA INNOPHARM PRIVATE LIMITED | $47.1K | 3 | 1 | $15.7K |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 165 | 23.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 121 | 17.0% |
| HYDERABAD AIR | 85 | 12.0% |
| HYDERABAD ACC (INHYD4) | 59 | 8.3% |
| NHAVA SHEVA SEA (INNSA1) | 40 | 5.6% |
| HYDERABAD ICD (INSNF6) | 33 | 4.6% |
| HYDERABAD ICD | 30 | 4.2% |
| Bombay Air | 22 | 3.1% |
VEA Impex (I) Private Limited exports 14 products worth $229.9K. Beyond Darunavir, top products include Daratumumab, Nivolumab, Cetuximab, Vinorelbine, Brufen. View the complete VEA Impex (I) Private Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Darunavir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for VEA Impex (I) Private Limited's Darunavir exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
VEA Impex (I) Private Limited
Full Company Profile →
14 products · $229.9K total trade · 3 categories
| MINISTRY OF HEALTH AND CHILD CARE |
| ZIMBABWE |
| $250.0K |
| 5 |
| MINISTERE DE SANTE PUBLIQUE | BENIN | $200.0K | 4 |
| XXPINXXHARXXCEUXXCALXXINC | UNITED STATES | $100.0K | 2 |
| LUPIN PHARMACEUTICAL INC | UNITED STATES | $100.0K | 2 |
| USAID UGANDA | KENYA | $100.0K | 2 |
India's Darunavir is purchased by 258 buyers worldwide. The top buyer is MYLAN IRELAND C/O ALLOGA RDC, (NETHERLANDS), followed by CIPLA USA INC UPS SUPPLY CHAIN SOLU and CSP VIATRIS SANTE AT CSP-LAB.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
VEA Impex (I) Private Limited ranks #9 among 28 Indian Darunavir exporters. Average shipment value of $14.9K compared to the market average of $1.2M. The closest competitors by value are LUPIN LIMITED and EMCURE PHARMACEUTICALS LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 114+ countries, 258+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for VEA Impex (I) Private Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Darunavir. For current shipment-level data, contact TransData Nexus.